Daniel Wollschläger1, Heiko Karle2, Marcus Stockinger2, Detlef Bartkowiak3, Sandra Bührdel3, Hiltrud Merzenich4, Thomas Wiegel3, Maria Blettner4, Heinz Schmidberger2. 1. Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Center Mainz, Germany. Electronic address: wollschlaeger@uni-mainz.de. 2. Department of Radiation Oncology, University Medical Center Mainz, Germany. 3. Department of Radiation Oncology, University Hospital Ulm, Germany. 4. Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Center Mainz, Germany.
Abstract
BACKGROUND AND PURPOSE: To analyze the distribution of individually-determined radiation dose to the heart and its functional sub-structures after radiotherapy in breast cancer patients treated in Germany during 1998-2008. MATERIAL AND METHODS: We obtained electronic treatment planning records for 769 female breast cancer patients treated with megavoltage tangential field radiotherapy. All dose distributions were re-calculated using Eclipse with the anisotropic analytical algorithm (AAA) for photon fields, and the electron Monte Carlo algorithm for electron boost fields. Based on individual dose volume histograms for the complete heart and several functional sub-structures, we estimated various dose measures in patient groups. RESULTS: Mean heart dose spanned a range of 0.9-19.1Gy for left-sided radiotherapy and 0.3-11.6Gy for right-sided radiotherapy. Average (median) mean heart dose was 4.6Gy (3.7Gy) for left-sided radiotherapy, and 1.7Gy (1.4Gy) for right-sided RT. With left-sided radiotherapy, 66% of the patients had 2cm(3) of the complete heart exposed to at least 40Gy. Younger age, higher body mass index, tumor location in a medial quadrant, and presence of a parasternal field were also associated with higher heart dose. CONCLUSION: Tumor location and treatment choices influence cardiac dose with complex interactions. There is considerable variability in heart dose, with dose metrics of different cardiac sub-structures showing different patterns in their dependency on external influences. Dose-response analysis of late cardiac effects after radiotherapy requires detailed individual dosimetry.
BACKGROUND AND PURPOSE: To analyze the distribution of individually-determined radiation dose to the heart and its functional sub-structures after radiotherapy in breast cancerpatients treated in Germany during 1998-2008. MATERIAL AND METHODS: We obtained electronic treatment planning records for 769 female breast cancerpatients treated with megavoltage tangential field radiotherapy. All dose distributions were re-calculated using Eclipse with the anisotropic analytical algorithm (AAA) for photon fields, and the electron Monte Carlo algorithm for electron boost fields. Based on individual dose volume histograms for the complete heart and several functional sub-structures, we estimated various dose measures in patient groups. RESULTS: Mean heart dose spanned a range of 0.9-19.1Gy for left-sided radiotherapy and 0.3-11.6Gy for right-sided radiotherapy. Average (median) mean heart dose was 4.6Gy (3.7Gy) for left-sided radiotherapy, and 1.7Gy (1.4Gy) for right-sided RT. With left-sided radiotherapy, 66% of the patients had 2cm(3) of the complete heart exposed to at least 40Gy. Younger age, higher body mass index, tumor location in a medial quadrant, and presence of a parasternal field were also associated with higher heart dose. CONCLUSION:Tumor location and treatment choices influence cardiac dose with complex interactions. There is considerable variability in heart dose, with dose metrics of different cardiac sub-structures showing different patterns in their dependency on external influences. Dose-response analysis of late cardiac effects after radiotherapy requires detailed individual dosimetry.
Authors: Jae Won Jung; Matthew M Mille; Bonnie Ky; Walter Kenworthy; Choonik Lee; Yeon Soo Yeom; Aaron Kwag; Walter Bosch; Shannon MacDonald; Oren Cahlon; Justin E Bekelman; Choonsik Lee Journal: Phys Imaging Radiat Oncol Date: 2021-08-23
Authors: Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald Journal: Transl Lung Cancer Res Date: 2017-12
Authors: Hiltrud Merzenich; Dan Baaken; Marcus Schmidt; Inga Bekes; Lukas Schwentner; Wolfgang Janni; Achim Woeckel; Detlef Bartkowiak; Thomas Wiegel; Maria Blettner; Daniel Wollschläger; Heinz Schmidberger Journal: Breast Cancer Res Treat Date: 2021-10-09 Impact factor: 4.872
Authors: C Simonetto; H Rennau; J Remmele; S Sebb; P Kundrát; M Eidemüller; U Wolf; G Hildebrandt Journal: Strahlenther Onkol Date: 2018-10-22 Impact factor: 3.621